glp-1 agonists australia Receptor Agonist Market Size & Outlook, 2033 GLP-1 RA and GIP +
Description
10.1371/journal.pone.0097554 38 KristensenS
doi: 10.3390/jcm10050985 174 UnniSWittbrodtEMaJSchauerhamerMHurdJRuiz-NegrnNet al
The GLP-1 Revolution: From Diabetes and Obesity to Alzheimers and PCOS GLP-1 agonists have soared in popularity thanks to their powerful efficacy in diabetes and obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 99.Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, et al
10.1093/jpp/rgad014 136 ZhangY.TangC.HeY.ZhangY.LiQ.ZhangT.et al (2024)
Iwai T, Sawabe T, Tanimitsu K, Suzuki M, Sasaki-Hamada S, Oka J
